Magnus Financial Group LLC Sangamo Therapeutics, Inc Transaction History
Magnus Financial Group LLC
- $1.01 Billion
- Q4 2024
A detailed history of Magnus Financial Group LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Magnus Financial Group LLC holds 10,000 shares of SGMO stock, worth $10,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$10,100
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SGMO
# of Institutions
141Shares Held
60.4MCall Options Held
1.46MPut Options Held
1.84M-
Vanguard Group Inc Valley Forge, PA9.37MShares$9.47 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT9.23MShares$9.32 Million0.05% of portfolio
-
State Street Corp Boston, MA5.02MShares$5.07 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$4.75 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$3.12 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $158M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...